• LivaNova completes TandemLife acquisition biospectrumasia
    April 08, 2018
    Under the terms of the agreement, LivaNova paid $200 million to TandemLife at closing with an additional $50 million to be paid based on specified regulatory milestones.
PharmaSources Customer Service